Literature DB >> 10602489

Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2.

N Foray1, V Randrianarison, D Marot, M Perricaudet, G Lenoir, J Feunteun.   

Abstract

There is now evidence to suggest that BRCA1 and BRCA2 are involved in the response of cells to DNA damage and cell cycle checkpoint control. This report examines the death pathways of human cells with various BRCA1 and BRCA2 genotypes after exposure to gamma-rays. A lack of functional BRCA1 and BRCA2 led to defective repair of DNA double-strand breaks in irradiated cells. This impairment resulted in a relaxation of cell cycle checkpoints, production of micronuclei, and a loss of proliferative capacity. Heterozygous BRCA1 and BRCA2 mutations also led to enhanced radiosensitivity, with an impaired proliferative capacity after irradiation. The existence of a phenotype related to radiosensitivity in BRCA1+/- and BRCA2+/- cells raises the question of the response of heterozygous women to radiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602489     DOI: 10.1038/sj.onc.1203165

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein.

Authors:  Nicolas Foray; Didier Marot; Anastasia Gabriel; Voahangy Randrianarison; Antony M Carr; Michel Perricaudet; Alan Ashworth; Penny Jeggo
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.

Authors:  Ram Fridlich; Devi Annamalai; Rohini Roy; Giana Bernheim; Simon N Powell
Journal:  DNA Repair (Amst)       Date:  2015-03-17

Review 3.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

Review 4.  Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  David J Hughes
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

5.  Primary squamous cell carcinoma of the endometrium unrelated to human papilloma virus: a molecular study.

Authors:  Giovanna Giordano; Silvia Pizzi; Cinzia Azzoni; Lorena Bottarelli; Tiziana D'Adda
Journal:  Pathol Oncol Res       Date:  2013-02-21       Impact factor: 3.201

6.  Evolutionary pathways in BRCA1-associated breast tumors.

Authors:  Filipe C Martins; Subhajyoti De; Vanessa Almendro; Mithat Gönen; So Yeon Park; Joanne L Blum; William Herlihy; Gabrielle Ethington; Stuart J Schnitt; Nadine Tung; Judy E Garber; Katharina Fetten; Franziska Michor; Kornelia Polyak
Journal:  Cancer Discov       Date:  2012-04-10       Impact factor: 39.397

7.  Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.

Authors:  Hiroyuki Konishi; Morassa Mohseni; Akina Tamaki; Joseph P Garay; Sarah Croessmann; Sivasundaram Karnan; Akinobu Ota; Hong Yuen Wong; Yuko Konishi; Bedri Karakas; Khola Tahir; Abde M Abukhdeir; John P Gustin; Justin Cidado; Grace M Wang; David Cosgrove; Rory Cochran; Danijela Jelovac; Michaela J Higgins; Sabrina Arena; Lauren Hawkins; Josh Lauring; Amy L Gross; Christopher M Heaphy; Yositaka Hosokawa; Edward Gabrielson; Alan K Meeker; Kala Visvanathan; Pedram Argani; Kurtis E Bachman; Ben Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

Review 8.  BRCA1 Mutation: A Predictive Marker for Radiation Therapy?

Authors:  Charlene Kan; Junran Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-01       Impact factor: 7.038

9.  TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

Authors:  Yang Peng; Hui Dai; Edward Wang; Curtis Chun-Jen Lin; Wei Mo; Guang Peng; Shiaw-Yih Lin
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

10.  Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.

Authors:  Ellen E McCarthy; Julide T Celebi; Richard Baer; Thomas Ludwig
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.